Anna Kofla-Dłubacz

Anna Kofla-Dłubacz

Auto-generated profile, based on publicly available information

Anna Kofla-Dłubacz

2nd Department and Clinic of Paediatrics, Gastroenterology and Nutrition, Wroclaw Medical University, Wroclaw, Poland

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 July 2024 in Pediatria i Medycyna Rodzinna
Verified
Journal Article
Open access
PDF file
PGPaula Grębska
Paula Grębska
MSMagdalena Szeląg
Magdalena Szeląg
ADAnna Dancewicz
Anna Dancewicz
AKAnna Kofla-Dłubacz
Anna Kofla-Dłubacz
ICIrena Choroszy-Król
Irena Choroszy-Król
TPTomasz Pytrus
Tomasz Pytrus
The high prevalence of autism spectrum disorder (ASD), the specificity of paediatric patients and the determination of their parents give rise to the growing interest of scientists in potential therapeutic approaches. There are multiple aetiological factors involved, and more will probably be discovered. Currently, the involvement of genetic and environmental factors in the aetiology is widely accepted. Growing evidence has been presented for the link between gut dysbiosis and autism. Analysing recent scientific reports, attention was drawn to the proportion and composition of gut microbiota in children with this diagnosis. These are mainly Bacteroidetes, Firmicutes and Actinobacteria, all of which were more abundant in children with ASD than in controls. In turn, children with ASD showed significantly higher counts of Bacteroides, Parabacteroides, Clostridium, Faecalibacterium and Phascolarctobacterium and lower percentages of Coprococcus and Bifidobacterium. If the initial hypotheses support microbial involvement in ASD-related symptoms, clinical trials with microbiota as a therapeutic target would be highly desirable. Recently, researchers have also been interested in faecal microbiota transplantation and microbiota transfer therapy. However, given the inconsistency in results between different centres, final conclusions cannot be reached. Differences in the composition of microbiota arise from, among others, the large age range of patients, which has a general impact on the variability of the microbiome composition over the years of life, environmental diversity with its dietary and cultural habits affecting the unique composition of the microflora, as well as food selectivity that is typically seen in ASD.

29 December 2023 in Pediatria i Medycyna Rodzinna
Verified
Journal Article
Open access
PDF file
PPPiotr Jan Potyrała
Piotr Jan Potyrała
MPMichał Puła
Michał Puła
TPTomasz Pytrus
Tomasz Pytrus
JKJoanna Kukawczyńska-Noczyńska
Joanna Kukawczyńska-Noczyńska
GSGirish Sharma
Girish Sharma
AKAnna Kofla-Dłubacz
Anna Kofla-Dłubacz

9 February 2022 in Nowotwory. Journal of Oncology
Verified
Journal Article
Open access
PDF file
AKAnna Kofla-Dłubacz
Anna Kofla-Dłubacz
ASAndrzej Stawarski
Andrzej Stawarski
TPTomasz Pytrus
Tomasz Pytrus
JGJustyna Gil
Justyna Gil
Von Hippel-Lindau disease and tuberous sclerosis are rare genetic disorders, which belong to the group of phacomatoses. They involve an increased risk of development of multiple cancers, mostly benign ones, which may undergo malignant transformation. Genetic diagnostic including identification of the pathogenic variant of the VHL and TSC1 and TSC2 genes enables optimisation of patient care and identification of relatives who carry the mutation. Von Hippel-Lindau disease and tuberous sclerosis are rare genetic disorders, which belong to the group of phacomatoses. They involve an increased risk of development of multiple cancers, mostly benign ones, which may undergo malignant transformation. Genetic diagnostic including identification of the pathogenic variant of the VHL and TSC1 and TSC2 genes enables optimisation of patient care and identification of relatives who carry the mutation.